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DOI 10.1016/j.immuni.2011.10.017SUMMARY via afferent lymph from LNs located upstream (Braun et al.,Little is known about mechanisms determining the
homeostasis of lymphocyteswithin lymphoidorgans.
Applying different mouse models, including condi-
tionally proficient Ccr7 gene-targeted mice, we now
show that semimature steady state dendritic cells
(sDCs) constitutively trafficking into lymph nodes
(LNs) were essential contributors to T cell homeo-
stasis in these organs. sDCs provided vascular endo-
thelial growth factor known to support high endothe-
lial venule formation, thus facilitating enhanced
homing of T cells to LNs. The presence of sDCs led
to increased CCL21 production in T-zone fibroblastic
reticular cells. CCL21 is a ligand for CCR7 known to
regulate homing as well as retention of T cells in
LNs. In addition, we provide evidence that CCL21
binds to the surface of DCs via its heparin-binding
domain, further explaining why T cells leave LNs
more rapidly in the absence of sDCs. Together, these
data reveal multiple roles for sDCs in regulating T cell
homeostasis in LNs.
INTRODUCTION
Secondary lymphoid organs, such as lymph nodes (LNs), play
an important role for the initiation and maintenance of adap-
tive immune responses. They provide the environment that
allows efficient interaction of different subsets of immune cells
with each other and with nonhematopoietic stromal cells. The
contact of naive T cells with dendritic cells (DCs) presenting
antigen in secondary lymphoid organs can serve as a paradig-
matic example demonstrating the need for controlled spatio-
temporal interaction of cells of the immune system. T cells
enter LNs from the blood via specialized high endothelial
venules (HEVs) applying a program of sequential adhesion
stages including the interaction of T cell-expressed selectins,
integrins, and chemokine receptors with their corresponding
ligands, which are expressed at the luminal side of HEVs
(for recent reviews, see von Andrian and Mackay, 2000; von
Andrian and Mempel, 2003). In addition, T cells may arriveI2011).
Whereas T cells continuously recirculate between secondary
lymphoid organs, immature DCs reside as sentinels in the skin
andmucosal surfaces (Banchereau and Steinman, 1998). There-
fore, DCs have to be mobilized from peripheral sites and migrate
via afferent lymphatics into the draining LN to present antigen to
those T cells carrying a cognate antigen receptor. Depending on
the nature of the antigen, thematuration status, and the subset of
DCs involved, this initial interaction either leads to the induction
of tolerance or protective immunity. Immunity is induced by DCs
that present antigens derived from pathogens (Steinman et al.,
2003), and steady state migratory sDCs presenting self-antigen
or innocuous environmental antigens under noninflammatory
situations to T cells induce tolerance (Lohr et al., 2005). Data ob-
tained from Ccr7-deficient mice revealed that this chemokine
receptor is essential for DCmobilization as well as T cell homing.
In Ccr7-deficient mice, LNs and Peyer’s patches are poor in
T cells and mature DCs and upon adoptive transfer into wild-
type recipients, Ccr7-deficient T cells are impaired in homing
to LNs (Fo¨rster et al., 1999).
Along the same line, DCs differentiated from bone marrow of
Ccr7-deficient mice do not migrate to the draining LN after
subcutaneous injection or intratracheal instillation (Hintzen
et al., 2006; Martin-Fontecha et al., 2003; Ohl et al., 2004).
Furthermore, applying in vivo mobilization assays such as fluo-
rescein-isothiocyanate (FITC) skin painting, Ccr7-deficient DCs
entirely fail to migrate to the draining LN (Fo¨rster et al., 1999).
After their intralymphatic injection, Ccr7-deficient T cells and
DCs also fail to migrate from their port of entry, the subcapsular
sinus, into the T cell area (Braun et al., 2011). Taken together,
these data identify CCR7 as a key regulator that control entry
of T cells and DCs to LNs. In contrast, the sphingolipid sphingo-
sine-1-phosphate (S1P) and one of its receptors, sphingosin-1-
phosphate receptor 1 (S1P1), have been identified as the key
molecules that regulate egress of lymphocytes from lymphoid
organs. Adoptively transferred S1P1-deficient T cells accumu-
late in lymphoid organs and mice deficient for sphingosine
kinase, an enzyme that is involved in S1P synthesis, have
enlarged LNs (Pappu et al., 2007). Recently, it has been sug-
gested that the balanced expression of CCR7 and S1P1 on
T cells as well as the spatial distribution of their cognate ligands
regulate the dwell time of T cells within LNs thus contributing to
LN homeostasis (Pham et al., 2008).mmunity 35, 945–957, December 23, 2011 ª2011 Elsevier Inc. 945
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generated mice conditionally expressing human CCR7 in a cell
type-specific manner. We show that mice expressing human
CCR7 in T cells only (T-CCR7+/+ mice) are devoid of LN T cells,
although T cells of these mice readily homed to LNs of wild-
type recipients after intravenous adoptive transfer. We further
observed that LNs of T-CCR7+/+ mice have reduced numbers
of HEVs resulting in reduced homing of T cells to LNs. In contrast,
mixed bone marrow chimeras possessing hematopoietic cells
fromWT and T-CCR7+/+mice as well as mice expressing human
CCR7 in T cells and in DCs (DC-T-CCR7+/+mice) showed normal
morphology and T cell counts. We found that DCs produce
vascular endothelial growth factor (VEGF) contributing to HEV
growth and thus lymphocyte homing. Furthermore, in the pres-
ence of DCs, T-zone fibroblastic reticular cells (TRCs) produced
increased amounts of CCL21. DCs can bind this chemokine to
their cell surface via its heparin-binding domain and thus provide
cues that allow T cells to stay for prolonged periods of time
within LNs.
RESULTS
Generating Humanized CCR7 Gene-Targeted Mice
To dissect the role of CCR7 on different immune cell populations,
we generated a mouse that allows a cell type-specific expres-
sion of CCR7. We applied an approach which allowed the induc-
tion of human CCR7 instead of the mouse ortholog (Figure S1
available online). This strategy was chosen because mouse
CCR7 ligands efficiently induce signals through human CCR7
(Campbell et al., 1998); still, mouse and human CCR7 protein
can be distinguished by means of species-specific antibodies.
The strain was designed to disrupt and terminate the murine
Ccr7 transcript by insertion of a loxP flanked neomycin (neo)
selection cassette and the humanCCR7 cDNA (Figure S1) which
could not be transcribed as long as the neo cassette was
present. These mice could neither express mouse nor human
CCR7 (Ccr7/CCR7stop/stop). After Cre-mediated recombina-
tion, the floxed neomycin cassette was excised to enable the
expression of a fusion transcript consisting of the first and
second exon of murine Ccr7 fused to an IRES element in front
of human CCR7. Translation of this transcript yielded exclusively
human CCR7. Notably, human CCR7 was expressed under the
control of the endogenous murine Ccr7 promoter and potentially
regulatory elements including the murine 30 UTR, which were left
intact. This strategy was chosen to ensure that the expression of
human CCR7 recapitulates expression of the endogenous
mouse Ccr7 gene. Further information regarding the construc-
tion of the targeting vector can be found in the Supplemental
Information.
We first crossed Ccr7/CCR7stop/stop mice to a transgenic
strain expressing Cre recombinase ubiquitously in early stages
of ontogeny yielding mice carrying human CCR7 alleles in all
cell types. The comparative analysis of CD4+ cells from periph-
eral blood of wild-type (Ccr7+/+; WT), heterozygous (Ccr7+/
CCR7+/), and homozygous human CCR7 (Ccr7/CCR7+/+)
mice applying mAb either specific for human or mouse Ccr7 re-
vealed that anti-murine Ccr7 bound towild-type cells and to cells
carrying one allele of both human and murine Ccr7, but failed to
bind to cells derived from mice carrying human CCR7 on both946 Immunity 35, 945–957, December 23, 2011 ª2011 Elsevier Inc.alleles (Figure 1A). Conversely, mAb to human CCR7 neither
bound to cells of wild-type mice nor to cells isolated from mice
still carrying the neomycin resistance gene. However, mice
carrying at least one humanCCR7 allele that lacked theneo resis-
tance cassette bound anti-human CCR7 (Figure 1A). Ccr7+/
CCR7+/mice were further subjected to flow cytometric analysis
demonstrating that all cells that expressed mouse Ccr7 also ex-
pressed the human ortholog and, vice versa, that human CCR7
was not expressed on cells that lacked expression of mouse
Ccr7 (data not shown).
Offspring of chimeric mice was also crossed to C57BL/6 mice
for six generations. Applying ‘‘speed genomics’’ parents of the
third to fifth generation were selected on the basis of their high
degree of C57BL/6 genomic background. F6 mice were then
crossed to mice expressing Cre under the control of the Cd4
promoter giving rise tomice that expressed humanCCR7 specif-
ically in T cells (T-CCR7+/+ mice; Figure 1B).
Together, these results indicate that the mice generated here
express human CCR7 instead of the mouse ortholog once the
neo cassette has been deleted. For reasons of convenience,
mice with two humanCCR7 alleles not carrying any neo because
of deletion at the germline (GL) level (Ccr7/CCR7+/+) will be
referred to as GL-CCR7+/+ mice throughout the manuscript.
Mice carrying human CCR7 as well as neo on both alleles
(Ccr7/CCR7stop/stop) will be referred to as CCR7stop/stop mice.
Mice generated by intercrossing Ccr7/CCR7stop/stop mice
with transgenic mice expressing Cre under control of the Cd4
promoter (Ccr7/CCR7+/+Cd4-cre+) will be referred to as
T-CCR7+/+ mice, whereas mice generated by intercrossing
Ccr7/CCR7stop/stop mice with Cd4-cre+ and Cd11c-cre+
(Ccr7/CCR7+/+Cd4-cre+Cd11c-cre+) that express human
CCR7 in T cells as well as DCs will be referred to as DC-T-
CCR7+/+ mice.
Human CCR7 Is Fully Functional in Mice
In transwell migration assays, T cells fromGL-CCR7+/+ and wild-
type mice showed a comparable chemotactic response toward
CCL21 whereas T cells from CCR7stop/stop mice did not migrate
toward this chemokine (Figure 1C). Furthermore, wild-type and
GL-CCR7+/+ T cells home to the same extent to secondary
lymphoid organs of wild-type recipient mice after intravenous
injection under competitive in vivo situations (Figure 1D). In addi-
tion, FITC skin painting revealed a similar result with regard to
homing efficacy. In these experiments, wild-type and GL-
CCR7+/+ DCs migrated to the same extent to the draining LNs,
whereasDCs fromCCR7stop/stopmicewere completely excluded
from LNs (Figure 1E).
As observed for GL-CCR7+/+ mice, T cells isolated from
secondary lymphoid organs of T-CCR7+/+mice migrated as effi-
ciently as wild-type cells toward CCL21 when tested in in vitro
transwell migration assays (Figure 1F). The T cell-specific
expression of human CCR7 could also be demonstrated func-
tionally, given that DCs of these animals neither migrated
in vitro toward CCL21 nor in vivo after FITC skin painting (Figures
1F and 1G).
LNs from wild-type as well as GL-CCR7+/+ mice contained
similar numbers of T lymphocytes, whereas LNs of CCR7stop/stop
mice were almost devoid of both CD4+ and CD8+ T cells (Fig-
ure 2A). Accordingly, immunohistology revealed prominent
Figure 1. Expression and Functional Analysis of Human and Mouse
Ccr7
(A) Flow cytometry of cells isolated from blood of wild-type (WT),CCR7stop/stop,
Ccr7+/CCR7+/, and GL-CCR7+/+ mice and analyzed for the expression of
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IT cell areas as well as distinct splenic periarteriolar lymphoid
sheaths (PALSs) filled with T cells in both wild-type as well as
GL-CCR7+/+mice, whereas inCCR7stop/stopmice the paracortex
of LNs as well as the splenic PALSs were largely devoid of T cells
(Figure 2B). Surprisingly, when analyzing T-CCR7+/+ mice we
observed that these mice showed a massive T cell lymphopenia
in LNs, which was similar to the one found in CCR7stop/stop mice
(Figure 2C), even though T and B cell counts in the peripheral
blood were only slightly altered (Figure 2D). Together, these
data indicate that the human ortholog of mouse CCR7 is fully
functional in mice but that expression of CCR7 on T cells is not
sufficient to overcome T cell lymphopenia in LNs.
Reduced Numbers but Fully Functional HEVs in Lymph
Nodes of T-CCR7+/+ Mice
In order to identify ‘‘non-T cell factors’’ involved in this process,
we applied adoptive cell transfers. T cells from wild-type and
CCR7stop/stop mice homed at comparable numbers to the
spleens of wild-type and T-CCR7+/+ recipients. In contrast, the
migration of cells from CCR7stop/stop donors to the peripheral
LNs of both recipient strains was impaired as a result of the
lack of CCR7 expression (Figure 3A). Interestingly, wild-type
T cells homed considerably less efficiently to brachial and
inguinal LNs of T-CCR7+/+ mice compared to wild-type recipi-
ents, being nearly as inefficient as T cells from CCR7stop/stop
donors (Figure 3A). These observations suggest that LNs of
T-CCR7+/+ mice might not provide the environment required
for efficient T cell homing to LNs or for the retention of T cells
in these organs.
We thus analyzed the HEVs in LNs of wild-type and T-CCR7+/+
mice. To this end, we stained inguinal LN cryosections withmurine (upper row) or human CCR7 (lower row). Shown are representative
results from four independent experiments (see also Figure S1).
(B) Expression of human CCR7 on blood CD4+ T cells, B cells, and spleen
CD11c+ DCs from WT, T-CCR7+/+, and CCR7stop/stop mice. The shaded areas
depict the isotype control.
(C) Chemotaxis of lymphocytes and DCs toward CCL21. Lymphocytes iso-
lated from spleen of WT; (black columns), GL-CCR7+/+ (green columns), and
CCR7stop/stop (blue columns) mice were analyzed for their ability to migrate
toward CCL21 (0 or 100 nM) within 3 hr (migration index; mean of triplicates +
SD of one representative experiment of five performed).
(D) In vivo migration of mouse lymphocytes expressing human CCR7.
Lymphocytes isolated from WT and GL-CCR7+/+ mice were labeled with
different fluorescent dyes (TAMRA, CFSE) and injected i.v. into WT recipients.
After 3 hr, cells were isolated from axillary (ALN), brachial (BLN), and inguinal
(ILN) lymph node and spleen (SPL) were stained for CD3 expression. The ratio
(+SD) of recovered CD3+ of GL-CCR7+/+/WT origin is shown (n = 8 recipients).
(E) In vivo FITC skin painting. Both ears of mice with the indicated genotype
were painted with FITC solution. Twenty-four hours later, single-cell suspen-
sions of the ear-draining LN were prepared and analyzed by flow cytometry.
Shown are absolute cell counts (+SD) of FITC+CD11c+MHCII+ cells (n = 4mice
per group; representative data from one of two experiments performed).
(F) Chemotactic migration of T cells (left) and DCs (right) toward CCL21. T cells
isolated from peripheral LNs, and mature BMDCs from WT (black column) or
T-CCR7+/+ (green column) mice migrated for 3 hr toward medium alone (0) or
300 nM CCL21 (mean +SD; n = 3).
(G) In vivo FITC skin painting of T-CCR7+/+ mice. Animals were painted with
FITC solution. Twenty-four hours later, single-cell suspensions of the facial LN
of WT, T-CCR7+/+, and CCR7stop/stop mice were analyzed by flow cytometry.
Shown are the cell numbers for the recovered FITC+CD11c+MHCII+ cells
(mean +SD, n = 8 LN of 4 mice/genotype).
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Figure 2. GL-CCR7+/+ Mice Show a WT Phenotype
(A) Distribution of CD4+ and CD8+ T cells in mesenteric and axillary lymph
nodes (MLNs and ALNs, respectively). Lymphocytes were isolated from WT
(black column), GL-CCR7+/+ (red column), and CCR7stop/stop (blue column)
littermates and stained with antibodies against CD4 and CD8. Absolute cell
counts are shown (mean +SD; pooled data from 2 to 8 mice).
(B) Immunohistology of ALN and spleen (SPL) of WT (top), GL-CCR7+/+
(middle), and CCR7stop/stop (bottom) mice. We stained 8 mm cryosections with
antibodies indicated. Shown are sections representative for six animals
analyzed per genotype.
(C) Distribution of CD4+ and CD8+ T cells in mesenteric LNs (MLNs), ALNs,
BLNs, and ILNs of WT (black columns), T-CCR7+/+ (green columns), and
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sections of each LN. On the basis of the DAPI staining, we deter-
mined the section area morphometrically and found it to be
reduced by 30%–40% in T-CCR7+/+mice (Figure 3B). The deter-
mination of the length of all CD31+MECA79+ HEVs present on
the entire LN section also demonstrated a 30% reduction in
T-CCR7+/+ mice compared to wild-type mice (Figure 3B).
However, because we calculated HEV length per mm2 section
area, we could not see any difference between wild-type and
T-CCR7+/+ animals, demonstrating that the size reduction of
the LNs of T-CCR7+/+ mice is proportional to the reduction in
the absolute numbers of HEVs. We next compared the capacity
of wild-type and T-CCR7+/+ HEVs to allow homing of wild-type
T cells. To this purpose, we transferred red-fluorescent,
TAMRA-labeled T cells into wild-type as well as T-CCR7+/+
recipients. Mice were sacrificed 30 min later; cyrosections of
their inguinal LNs were stained with MECA79 mAb. The number
and position of the adoptively transferred cells relative to HEVs
was analyzed.With regard to the location of the adoptively trans-
ferred cells, five different positions were determined: (1) within
the lumen of a HEV; (2) attached to the luminal site of the
HEVs; (3) within HEVs; (4) at the abluminal site of the HEVs;
and (5) within tissue (Figure 3C). With the exception of cells
located within the HEV lumen, we found significantly more adop-
tively transferred cells per entire LN section in wild-type recipi-
ents at all sites analyzed (Figure 3D). However, we could
not find any significant difference between wild-type and
T-CCR7+/+ recipients once numbers of homed cells were calcu-
lated per section area unit (Figure 3E). Collectively, these find-
ings show that LNs of T-CCR7+/+ mice have less HEVs than
LNs of wild-type mice but suggest that these HEVs are
functional.
DC Migration and Lymph Node T Cell Homeostasis
To test the idea that lack of sDCs in T-CCR7+/+ mice might
contribute to the observed LN lymphopenia, we subcutaneously
injected TAMRA-labeled semimature wild-type bone marrow-
derived dendritic cells (BMDCs) into the left foot pad and PBS
into the right foot pad of T-CCR7+/+ mice. After 5 days, mice
were sacrificed and popliteal LNs (popLNs) were analyzed by im-
munohistology. Compared to PBS-draining LNs, DC-draining
LNs showed a strong increase in size (Figures 4A and 4C). The
LN that received the transferred DCs also showed a regularly
developed paracortex full of T cells in contrast to LNs draining
the applied PBS (Figure 4A). Additionally, DC-draining LNs
showed increased numbers of MECA79+ HEVs (Figures 4B
and 4D), indicating that trafficking of sDCs from the periphery
contributed to HEV development. Further analysis revealed
a high correlation between LN cellularity and the number of
adoptively transferred semimature DCs reaching the popLNs
(Figure 4E). Furthermore, DC-draining popLN displayed a 3-
fold increase in VEGF levels compared to PBS-draining LNs,CCR7stop/stop (blue columns) mice. Absolute cell counts were determined for
CD4+ and CD8+ T cells (mean + SD; n = 3 mice/genotype; shown is one
representative experiment of four experiments performed).
(D) Distribution of CD3+ and CD19+ cells in peripheral blood (PB) of WT,
T-CCR7+/+, and CCR7stop/stopmice as indicated (mean + SD, n = 5 to 29 mice/
genotype).
Figure 3. Reduced Homing of WT T Cells to T-CCR7+/+ Recipients
(A) Cells isolated from LNsand spleens ofWT (black columns) andCCR7stop/stop
(green columns) mice were labeled with TAMRA and CFSE, respectively.
Labeled cells were i.v. transferred to WT or T-CCR7+/+ recipients as indicated.
Three hours after injection, the mice were sacrificed and lymphocytes were
isolated fromSPL, ALNs, BLNs, and ILNs to recover transferred cells. Absolute
cell count of recovered CD3+ lymphocytes are shown (mean +SD; n = 4
recipients/group).
(B)Measurement of high endothelial venule (HEV) length and LN section area in
WT (black columns) and T-CCR7+/+ (green columns) mice. ILN cryosections
were stained with anti-CD31 and Meca79 mAb and DAPI and analyzed by
fluorescent microscopy and morphometry. On the basis of DAPI staining, the
LN section area (left panel) has been determined. The length (mm) of the HEVs
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Ias detected by ELISA (Figure 4F). To demonstrate that the DCs
themselves were a source of VEGF, we tested their capacity to
secrete VEGF. ELISA revealed that 100,000 semimature BMDCs
produced 10 pg VEGF in 24 hr (data not shown). Furthermore,
qRT-PCR on T cells and DCs isolated by flow sorting from
peripheral LNs of C57BL/6 mice confirmed that DCs were a rele-
vant source of VEGF (Figure 4G). To further confirm the idea that
sDC contribute to LN homing, we s.c. injected semimature
BMDCs or PBS in the hind flank of mice. After 5 days, these
mice i.v. received TAMRA-labeled T cells from wild-type donors
for 3 hr. The s.c. transfer of DCs led to a 4-fold increase in
short-term homing of T cells. Together, these data suggest
that the migration of DCs to LNs contribute to HEV formation
and efficient homing of T cells (Figure 4H).
Rag2-Deficient Bone Marrow Chimeras Rescue the
Phenotype of T-CCR7+/+ Mice
To further address the role of steady state DC migration on LN
T cell homeostasis, we generated Rag2/ + T-CCR7+/+ /
T-CCR7+/+ bone marrow chimeras. To this end, we lethally irradi-
ated T-CCR7+/+ mice and reconstituted them with either
T-CCR7+/+ bone marrow (T-CCR7+/+/ T-CCR7+/+) or a mixture
of 20% T-CCR7+/+ and 80% Rag2/ bone marrow
(T-CCR7+/+ + Rag2/ / T-CCR7+/+). All lymphocytes present
in the latter mice are of T-CCR7+/+ origin, whereas a considerable
part of the nonlymphoid hematopoietic cells, including DCs, are
derived from Rag2/ progenitors, thus carrying both mouse
Ccr7 alleles.
Analyzing bonemarrow chimeras 8 weeks after reconstitution,
we found that LNs of T-CCR7+/+ + Rag2/ / T-CCR7+/+
chimeras contained increased numbers of CD11c+MHCIIhigh
cells compared to T-CCR7+/+/ T-CCR7+/+ mice. Interestingly,
in contrast to the T-CCR7+/+/ T-CCR7+/+ chimeras, the vast
majority of DCs present in the T-CCR7+/+ + Rag2/ /
T-CCR7+/+ chimeras expressed mouse CCR7 (Figure 5A).
Furthermore, immunohistology revealed that LN paracortices
in T-CCR7+/+ + Rag2/ / T-CCR7+/+ chimeras were filled
with T cells, whereas the corresponding area in LNs of
T-CCR7+/+ / T-CCR7+/+ mice were largely devoid of T cells
(Figure 5B). A flow cytometry-based analysis of LNs confirmed
strongly increased T cell counts in T-CCR7+/+ + Rag2/ /
T-CCR7+/+ chimeras (Figure 5C).
On the basis of the observation that the paracortex of LNs from
T-CCR7+/+ + Rag2/ / T-CCR7+/+ chimeras was filled withhas been determined on the basis of CD31+Meca79+ endothelial cells (middle
panel). The right panel indicates the length of the HEVs in relation to the section
area of the LN (mean + SD; n = 16 section derived from 8 ILNs per group).
(C) Adoptive transfer of WT T cells in WT and T-CCR7+/+ mice. Lymphocytes
were isolated from peripheral LNs and spleen of WTmice, pooled, and MACS-
sorted for T cells. After labeling with TAMRA, T cells were injected into the tail
vein for 30min. We stained 8 mmcryosections of the ILN of recipients with anti-
CD31 andMeca79mAb. Themicrographs display the positions (I–V) of labeled
T cell that were analyzed in (D): (I) inside HEV without obvious contact to
endothelial cells; (II) attached to the luminal surface of HEV; (III) between HEV
endothelial cells; (IV) attached to the abluminal surface of HEV; and (V) in the
LN without obvious contact to HEV.
(D and E) Cell counts of transferred T cells in ILNs of WT (dots) and T-CCR7+/+
(triangles). Cell counts of transferred T cells are shown per LN section (D) or per
LN section area (E, dots and triangles indicate individual sections, and red bars
mean values obtained from 16 sections of 8 ILN per genotype).
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Figure 4. DCs Express VEGF and Induce HEV Growth
(A and B) Semimature BMDCswere injected s.c. into the right and PBS into the
left flank and footpad of T-CCR7+/+ mice. Immunohistology of popLNs of
T-CCR7+/+ mice 5 days after s.c. injection of semimature BMDCs into the
footpad. We stained 8 mm cryosections of 6- to 8-week-old mice with anti-
bodies against CD3 (green) and B220 (red; A) or MECA79 (B). Shown are
sections representative for nine LNs analyzed per group.
(C) Analysis of the section area of popLNs in T-CCR7+/+ mice 5 days after s.c.
injection of PBS or semimature BMDCs into the footpad. Dots indicate LNs
from nine mice; red bars indicate mean values.
Immunity
Dendritic Cells and T Cell Homeostasis
950 Immunity 35, 945–957, December 23, 2011 ª2011 Elsevier Inc.T cells, we speculated that the continuous homing of DCs to LNs
not only might affect T cell homing but also the LN dwell time of
T cells. To test this hypothesis, we aimed to address how fast
T cells leave skin-draining LNs of wild-type and T-CCR7+/+
mice. To that end, we TAMRA-labeled pooled lymphocytes
from wild-type spleen and LNs, which contained 45% T cells,
and adoptively transferred them to wild-type and T-CCR7+/+
recipients. After 20 hr, half of the animals of each group were
sacrificed, and the remaining recipients i.v. and i.p. received
anti-L-selectin antibodies (MEL-14) for preventing further
homing of recirculating lymphocytes before they were analyzed
14 hr later. We found that, before applying the anti-L-selectin
mAb, 78.7% ± 6.0% of the transferred cells homing to wild-
type LNs were T cells. After anti-L-selectin mAb treatment, this
value slightly decreased to 72.0% ± 11.7%. In contrast, in LNs
of T-CCR7+/+mice, the frequency of T cells within the transferred
cells dropped from 64.2% ±7.6% before to 35.8% ± 9.0% after
anti-L-selectin treatment (Figure 5D; mean ± SD; n = 35 LNs of 7
animals per group analyzed in two independent experiments).
Together, these findings indicate that under steady state condi-
tion, T cells are less efficiently retained in the LNs of T-CCR7+/+
mice compared to wild-type mice.
Increased CCL21 Levels in Lymph Nodes
of T-CCR7+/+ + Rag2–/– Chimeras
On the basis of the above described results and because of
the observation that T cells accumulate in the T cell zone of
T-CCR7+/+ + Rag2/ / T-CCR7+/+ chimeras, we speculated
that non-T cell factorsmight be responsible for the reduced dwell
time observed in T-CCR7+/+mice. Given that Ccr7 expression on
T cells has recently be described to affect their retention in LNs
(Pham et al., 2008), we analyzed the expression of CCL21 in
the above described T-CCR7+/+ + Rag2// T-CCR7+/+ and
T-CCR7+/+/ T-CCR7+/+ chimeras. Staining cryosections with
anti-CCL21, we observed in both experimental groups expres-
sion of CCL21 in HEVs and cells within the T cell areas. However,
the staining of CCL21 on cells within the T cell area was appar-
ently brighter in T-CCR7+/+ + Rag2// T-CCR7+/+ chimeras
compared to the T-CCR7+/+/ T-CCR7+/+ chimeras (Figure 5E).
A quantitative morphometric expression analysis over the LN
sections confirmed a 2-fold increase of CCL21 expression per(D) Measurement of high endothelial venule (HEV) length in popLNs of
T-CCR7+/+ 5 days after s.c. injection of PBS or semimature BMDCs into the
footpad. HEV length has been determined as described in Figure 3B. Dots
indicate LNs from nine mice; red bars indicate mean value.
(E) Semimature BMDCs were labeled with CFSE and then injected s.c. in the
flank and footpad of T-CCR7+/+ mice. After 5 days, the cellularity of the
draining LNs has been determined and correlated to the number of homed
DCs. ‘‘R’’ indicates the correlation constant. Dots indicate individual LNs.
(F) popLNs from T-CCR7+/+ mice receiving PBS or DCs s.c. into the footpad
were harvested at day 5 and analyzed for the expression of VEGF with ELISA.
Dots indicate individual LNs.
(G) DCs and T cells were sorted from LN by flow cytometry and analyzed by
qRT-PCR for the expression of VEGF-A (mean +SD; n = 4; data were derived
from at least two independent experiments).
(H) Ccr7-deficient mice were injected s.c. with PBS or 2 3 106 WT BMDCs.
After 5 days, T cells were isolated from WT donors, labeled with TAMRA, and
i.v. transferred (5.8 3 106). After 3 hr, recipients were sacrificed and the
number of TAMRA+ cells was determined in the ingLNs (mean +SD, n = 4–5
mice/per group from two independent experiments).
Figure 5. Rag2–/– + T-CCR7+/+/ T-CCR7+/+BoneMarrow Chimeras
Show Filled T Cell Areas and Increased Expression of CCL21
(A) Flow cytometry of cells isolated from peripheral LNs of T-CCR7+/+ /
T-CCR7+/+ chimeras (left) and Rag2/ + T-CCR7+/+ / T-CCR7+/+ (right)
chimeras. The expression of human CCR7 is shown for MHC-II+ CD11c+ cells.
(B) Immunohistology of peripheral LN of T-CCR7+/+/ T-CCR7+/+ (left) and
Rag2/ + T-CCR7+/+/ T-CCR7+/+mice. We stained 8 mm cryosections with
antibodies against CD3 (green) and B220 (blue).
(C) B and T cell counts (mean + SD) of lymphocytes isolated from peripheral
LNs of T-CCR7+/+ / T-CCR7+/+ mice (T-CCR7-Ch, filled column) and
Rag2/ + T-CCR7+/+ / T-CCR7+/+ chimeras (T-CCR7-Rag2/-Ch, open
column). In (A)–(C), data of n = 10 and 20 LNs.
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Ipixel in T-CCR7+/+ + Rag2/ / T-CCR7+/+ chimeras (Fig-
ure 5F). Because LNs of T-CCR7+/+ + Rag2/ / T-CCR7+/+
mice harbor skin-derived DCs, we hypothesized that these cells
might have contributed to the increased CCL21 levels observed
in the chimeric LNs, even though mouse DCs do not express
CCL21 by themselves (Link et al., 2007). Analysis of the draining
LNs of T-CCR7+/+ mice that s.c. received semimature DCs or
PBS 4 days earlier revealed a more than 2-fold increase in the
levels of CCL21 per LN in the group that received the DCs (Fig-
ure 5G). These results indicate that the presence of DCs might
enhance the production of CCL21 in LNs.
Expression of CCR7 on T Cells and DCs Restores LN
Homeostasis
The T-CCR7+/+ + Rag2/ / T-CCR7+/+ chimeras did not
restore CCR7 selectively on DCs but potentially also on other
cells. To overcome this limitation, we crossed Cd11c-cre+
mice to the T-CCR7+/+ mice, which led to the generation of
mice expressing human CCR7 on T cells as well as DCs but
not on B cells (DC-T-CCR7+/+ mice; Figure 6A). Human CCR7
was also not expressed on plasmacytoid (p)DCs but slightly ex-
pressed on lymphoid tissue inducer (LTi) cells (Figures S2A and
S2C) but both populations were surprisingly slightly reduced in
LNs of DC-T-CCR7+/+ mice (Figures S2B and S2D). Analysis of
skin-draining LNs revealed that T cells as well as DCs were
strongly diminished in number in T-CCR7+/+ mice, whereas
they were present at comparable numbers in the LNs of DC-T-
CCR7+/+ and wild-type mice. We also observed some reduction
of B cells in T-CCR7+/+mice but regular counts in DC-T-CCR7+/+
animals, suggesting that the presence of DCs, either directly or
indirectly, possibly by increasing the T cell numbers within
LNs, might also have some effect on LN B cell homeostasis (Fig-
ure 6B). Immunohistology revealed regular morphology of LNs
and spleen of DC-T-CCR7+/+ mice with large numbers of
T cells and DCs residing in LN paracortex and the splenic white
pulp, respectively (Figure 6C).
The main source of CCL21 within LNs are TRCs, but these
cells rapidly lose the capacity to produce this chemokine once
they are removed from their natural environment and being
cultured in vitro (Link et al., 2007). To test whether DCs
contribute to expression of CCL21 by TRCs, we isolated TRCs
from wild-type, CCR7stop/stop, T-CCR7+/+, and DC-T-CCR7+/+(D) Egress of lymphocytes in the peripheral LNs of WT and T-CCR7+/+ mice.
TAMRA-labeled WT cells were transferred toWT and T-CCR7+/+mice. Twenty
hour later, one part of the mice was sacrificed while the other part was treated
with the L-selectin blocking antibody Mel 14. Another 14 hr later, treated mice
were sacrificed. Lymphocytes were isolated from peripheral LNs and analyzed
by flow cytometry. The panel shows the percentage of CD3+ cells within the
transferred cells of antibody treated and untreated WT and T-CCR7+/+ mice
(7 mice with n = 35 LNs analyzed per group in two independent experiments;
dots show represent individual LNs).
(E) Analysis of CCL21 expression in peripheral LNs of T-CCR7+/+ /
T-CCR7+/+ and Rag2/ + T-CCR7+/+ / T-CCR7+/+ chimeras. Crysections
were stained and analyzed for the expression of CCL21 (red).
(F) The panel indicates themean of CCL21 intensity per pixel of LN cryosection
of T-CCR7+/+/ T-CCR7+/+ mice (T-CCR7-Ch, filled circles) and Rag2/ +
T-CCR7+/+/ T-CCR7+/+ chimeras (T-CCR7-Rag2/-Ch, open circles). Each
circle represents the intensity per pixel of one LN cryosection.
(G) The amount of CCL21 present in the inguinal LN of T-CCR7+/+ mice 5 days
after the s.c. footpad injection of PBS or DCs.
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Figure 6. Mice Expressing CCR7 on DCs and T Cells Show a Regular
Phenotype
(A) Expression of humanCCR7 on T cells, B cells, andDCs isolated from LNs of
DC-T-CCR7+/+ mice.
(B) Quantitative analysis of T cells (CD3+B220), DCs (CD11c+ MHC II high),
and B cells (B220+CD3) in ALN and popLN of WT, T-CCR7+/+ and DC-T-
CCR7+/+ mice as indicated (dots represent individual mice, pooled data
derived from three to four independent experiments).
(C) Immunohistology of cryosections of LN (left) and spleen (right) from DC-T-
CCR7+/+ mice; green, anti-B220; blue, anti-CD3; red, anti-CD11c; represen-
tative data of more than 5 animals analyzed).
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952 Immunity 35, 945–957, December 23, 2011 ª2011 Elsevier Inc.mice and determined CCL21 expression relative to GAPDH by
qRT-PCR. Interestingly, TRCs isolated from DC-T-CCR7+/+
mice expressed CCL21 at similar levels to those isolated from
wild-type LNs, whereas the expression of CCL21 by TRCs iso-
lated from both CCR7stop/stop and T-CCR7+/+ mice was reduced
to 50% of the wild-type levels (Figure 6D). Collectively, these
data indicate that expression of CCR7 on DCs is essential for
T cell homeostasis in LNs and that steady state-trafficking DCs
contribute to some degree to CCL21 expression in these organs.
DCs Bind Stromal Cell-Derived CCL21
As mentioned before, mouse DCs do not express CCL21 (Link
et al., 2007). Still we detected high amounts of CCL21 in the
T cell area of T-CCR7+/+ + Rag2/ / T-CCR7+/+ chimeras.
We therefore tested whether DCs in lymphoid organs not only
contribute to CCL21 production by TRCs but also bind this che-
mokine, leading to its retention within LNs. Indeed, immunohis-
tology of LN sections from untreated wild-type mice revealed
costaining of CD11c and CCL21 (Figure 7A), indicating that
DCs bind CCL21 as described by others before (Friedman
et al., 2006). Furthermore, DCs isolated from peripheral LNs
from wild-type but not from plt/plt mice carried CCL21 on their
cell surface as revealed by flow cytometry (Figure 7B). Incu-
bating BMDCs from wild-type and Ccr7-deficient mice with
different concentrations of recombinant CCL21 and then stain-
ing them with anti-CCL21 revealed that BMDCs strongly bind
CCL21 and that this binding to a large degree did not occur via
binding to CCR7 because it was also observed onCcr7-deficient
DCs (Figure 7C and data not shown). However, preincubation of
CCL21 with different concentrations of Heparin before or at the
time of DC staining completely interfered with the binding of
CCL21 to DCs (Figure 7C and data not shown). This suggests
that DCs bind CCL21 via its heparin-binding domain. To exper-
imentally address whether CCL21 binds to sulphated proteogly-
cans on the surface of DCs, we differentiated BMDCs in the
presence of NaClO3, which inhibits chondroitin and heparan sul-
fation (Humphries and Silbert, 1988). Indeed, the addition of
NaClO3 to the culturemedium for the last 3 days of differentiation
prevented the binding of exogenously added CCL21 to DCs (Fig-
ure 7D). Together with the Heparin blocking experiments, these
data strongly suggest that CCL21 efficiently binds to DCs via its
heparin-binding domain.
DISCUSSION
The importance of continuous afferent lymph flow for LN homeo-
stasis has been shown earlier by Mebius et al. (1991). Data from
the present study indicate that a CCR7-dependent steady state
migration of DCs into LNs is a key event for the maintenance of
unperturbed LN T cell homeostasis. We provide evidence that
steady sDCs reaching LNs via the afferent lymph are involved
at least in three different processes that contribute to LN T cell
homeostasis. sDCs (1) produce VEGF, which is known to act(D) TRCs were isolated by flow cytometry from mice with the genotype indi-
cated and assessed by qRT-PCR for the expression of CCL21 relative to
GAPDH (mean +SD, pooled data from multiple qRT-PCR runs with mRNA
isolated from 4 independent experiments).
Figure 7. DCs ‘‘Present’’ CCL21 on Their Surface
(A) Colocalization of CD11c and CCL21 on cryosections from LNs of C57BL/6
mice.
(B) Cells isolated from the inguinal LNs of wild-type or plt/pltmice were stained
with anti-MHCII-FITC, anti-CD11c-APC, and anti-CCL21/donkey-anti-goat-
bio/streptavidin-PerCP. Shown is CCL21 expression of CD11c+MHCII+ cells.
(C) WT or Ccr7-deficient bone marrow derived DCs were incubated with
2.5 mg/ml CCL21 (black line) alone or together with 1.25 U heparin (blue line).
After extensive washing, binding of CCL21 to DCs was revealed by flow
cytometry applying CCL21 antibodies.
(D) WT BMDCs were differentiated in vitro in the absence (black line) or
presence of NaClO3 (red line) for the last 3 days of culture. DCswere incubated
with CCL21 and stained for CCL21 binding as described for (C). Solid lines
represent CCL21 staining on DCs. Gray areas represent the control. Shown
are representative results from at least three independent experiments.
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Ias a growth and differentiation factor for HEVs thus allowing the
efficient homing of T cells to LNs, (2) support CCL21 expression
by TRCs, and (3) bind CCL21 produced by TRCs, thereby
providing retention signals that prolong the dwell of T cells
within LNs.
Although it has been well established that different classes of
adhesionmolecules are essentially involved in LN homing (Sack-
stein, 2005; von Andrian andMempel, 2003), little is known about
factors that control lymphocyte egress. On the basis of gene-tar-
geting in mice, sphingosin-1-phosphate receptor 1 (S1P1) has
been identified as a key regulator of lymphocyte egress (Cyster,
2005; Rosen et al., 2007). As a mode of action, it seems that LN
egress might reflect a S1P1-mediated chemotactic response of
T cells toward high levels of S1P present in the efferent lymph
fluid within medullary or cortical sinuses. From the observation
that Ccr7-deficient T cells egress more efficiently from LNs
than wild-type T cells, it has been suggested that S1P-egress-
promoting signals are counteracted by CCL21 expressed by
TRCs (Pham et al., 2008). Data from the present study support
and extend this model: We show that LNs of a conditional
T-CCR7+/+ proficient strain are lymphopenic probably as a result
of reduced levels of CCL21 present in the T cell zone, which in
turn is owed to impaired steady state migrating DCs, not only
supporting TRCs to express CCL21 but also contributing to
present CCL21 to T cells. Considering the fact that DCs build
a dense network within the T cell zone it seems plausible that
DCs substantially increase the area for CCL21 trapping and
presentation.
Althoughwecannot formally exclude thepossibility that human
CCR7 might not work exactly as murine Ccr7 in mice, data ob-
tained from the GL-CCR7+/+ mice strongly indicate that human
CCR7 can fully substitute for Ccr7 deficiency. Therefore, it was
unexpected to see that the T-CCR7+/+ mice have strongly
reduced LN T cell counts. Adoptive transfers revealed that
considerably less wild-type donor cells were present in
T-CCR7+/+ recipients than in wild-type recipients 3 hr after trans-
fer indicating that non-T cell factors might cause LN T cell lym-
phopenia in T-CCR7+/+ mice. The LNs of the latter animals have
30% to 40% less HEVs. Despite of the reduced numbers of
HEVs observed in the LNs of T-CCR7+/+ mice, short-term adop-
tive transfers of wild-type donor cells in wild-type and T-CCR7+/+
mice suggest that thoseHEVspresent seem tobe fully functional.
Under inflammatory conditions, DCs have been identified as
a source for VEGF that triggers vascular growth, includingmmunity 35, 945–957, December 23, 2011 ª2011 Elsevier Inc. 953
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with increased lymphocyte entry into LNs (Webster et al., 2006).
Data from the present study indicates that also in the steady
state, DCs directly contribute to HEV growth. After subcuta-
neous injection of cluster-disrupted semimature BMDCs, which
produce VEGF to relevant amounts, into T-CCR7+/+ recipients
we observed increased numbers of HEV endothelial cells and
increased VEGF expression in the draining LNs. Furthermore,
we detected considerable VEGF production by DCs isolated
from untreated LNs. However it seems also possible that DCs
might have indirect effects on HEV growth via interactions
with TRCs, which are a known source of VEGF (Chyou et al.,
2008).
In addition to their effect on HEVs, several lines of evidence
from the present study support the idea that sDCs also affect
the dwell time naive T cells stay within a LN: (1) In contrast to
T-CCR7+/+ / T-CCR7+/+ chimeras, T-CCR7+/+ + Rag2/ /
T-CCR7+/+ chimeras not only possess regular frequencies of
LN DCs but also a 3-fold increase in T cell numbers. (2) DC-T-
CCR7+/+ mice, expressing CCR7 on T cells and DCs, show
normal frequencies of LN T cells and regular architecture of the
T cell zone, and (3) adoptively transferred T cells egress more
quickly from LNs of T-CCR7+/+ than from wild-type recipients
under steady state, noninflammatory conditions. It is still not
entirely clear how DCs affect the dwell time of T cells but data
provided here would suggest that the CCL21-CCR7 axis is
involved. A recent study failed to detect CCL21 mRNA in LN
DCs in mice, rendering the possibility unlikely that DCs serve
as a direct source for CCL21 (Link et al., 2007). Showing that
TRCs in vivo express elevated levels of CCL21 mRNA in the
presence of DCs and that CCL21 can bind to the surface of
DCs independent of the presence of CCR7, our data would
support a model in which DCs promote CCL21 production by
TRCs and potentially help to ‘‘present’’ it to other cells such as
T cells. However, we cannot rule out that other cells than DCs ex-
pressing CCR7 are also involved in maintaining LN homeostasis.
We could recently demonstrate that mouse pDC are strongly
reduced in Ccr7-deficient mice and that pDCs express very
low levels of Ccr7 (Seth et al., 2011). On the basis of this very
weak expression of the endogenous Ccr7, we expectedly failed
to reveal expression of human CCR7 on pDCs once Cd11c-cre+
mice had been crossed in. Because DC-T-CCR7+/+ mice also
showed close to normal pDC counts, further studies have to
clarify a potential role for pDCs in LN homeostasis. Another
important cell population that expresses Ccr7 is LTi cells, which
are known to express CD4 in mice (Mebius et al., 1997). When
comparing the expression levels of human CCR7 in the
T-CCR7+/+ mice with that of mouse Ccr7 reported earlier on
LTi cells (Ohl et al., 2003), we found similarly low levels. It was
thus unexpected to observe reduced numbers of LTi cells in
T-CCR7+/+ mice but not in CCR7stop/stop or DC-T-CCR7+/+
mice. Given that we found a strong variation in the number of
LTi cells within individual LNs of all genotypes, we think that it
is rather unlikely that reduced numbers of LTi cells contribute
to LN homeostasis. Yet we can currently not exclude this possi-
bility. Furthermore, we can also not rule out the possibility that
lack of sDCs affect the integrity of the lymphatic endothelial cells
lining the medullary and cortical sinuses, which in turn could
allow a more rapid egress of T cells.954 Immunity 35, 945–957, December 23, 2011 ª2011 Elsevier Inc.A central role for DCs has been recently reported for the initi-
ation and maintenance of induced bronchus-associated
lymphoid tissue (iBALT) (GeurtsvanKessel et al., 2009; Halle
et al., 2009). Of interest, signaling through the lymphotoxin
beta receptor (LTb-R) seems to play an essential role in this
process given that delivery of a soluble LTb-R led to the disinte-
gration of iBALT. In this context, it is also noteworthy to mention
that LTb-R signaling has been identified to be essential for HEV
formation and maintenance (Browning et al., 2005). Thus, it
seems possible that LTbR signaling in DCs could be involved
in HEV formation potentially via VEGF production.
We and others could recently reveal that CCL21 provides
strong haptokinetic stimuli to T cells (Huang et al., 2007; Okada
and Cyster, 2007; Worbs et al., 2007). Thus, decreased levels of
CCL21 could influence the migration behavior, in particular of
such T cells moving during random walk toward cortical or
medullary sinusoids where they would be exposed to an
egress-promoting S1P gradient. In this model, promigratory
CCR7 signals would keep T cells on the TRC network, thus
making them less susceptible to react to the S1P1-mediated
egress signal. A similar effect might be exerted by increased
scanning activity on DCs displayed by T cells in the presence
of CCR7 ligands (Friedman et al., 2006). Once CCR7 is less
well triggered because of reduced availability of CCL21 in the
T cell area, T cells might be less efficiently retained and, conse-
quently, possess a higher propensity to leave the LNs via efferent
lymphatics. This model is supported by Cyster and colleagues
showing that Ccr7-deficient T lymphocytes egress more quickly
from LNs than wild-type T cells (Pham et al., 2008) and is also in
linewith previous studies from our group showing thatCcr7-defi-
cient B cells are not retained within the T cell zone but rapidly
move to B cell follicles (Fo¨rster et al., 1999).
Interestingly, applying in vivo two-photon microscopy studies,
we and others reported earlier that in all situations in which either
CCR7 or its ligands were missing, T cells migrated with reduced
directionality and velocity (Huang et al., 2007; Okada and Cyster,
2007; Worbs et al., 2007), suggesting that CCR7 ligands might
help to retain T cells on the TRCs network as originally described
in a pivotal study by Germain and colleagues (Baje´noff et al.,
2006).
Furthermore, we could recently show that naive T cells home
to LNs not only via HEVs but also via afferent lymphatic vessels.
Although both wild-type and Ccr7-deficient T cells entered the
LN via the peripheral medullary sinus after intralymphatic injec-
tion only wild-type, but not Ccr7/, T cells were able to migrate
from the medullary cord into the deep LN paracortex (Braun
et al., 2011). Wild-type T cells migrate into the LN paracortex
probably by following a gradient of immobilized CCL21 or
CCL19, which serves as another ligand for CCR7. In the present
study, we did not address a potential role for the latter chemo-
kine in LN T cell homeostasis. This was primarily due to the
fact that we were not able to detect staining of CCL19 on
LN sections with the reagents currently available (data not
shown).Thus, we cannot formally exclude that CCL19 contrib-
utes to the homeostasis of T cells in LN. However, on the basis
of studies usingCcl19-deficient mice that show regular LN archi-
tecture and normal T cell counts in LNs (Link et al., 2007), it
seems likely that CCL21 rather than CCL19 might be the key
player in CCR7-mediated LN homeostasis.
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steady state-trafficking DCs in LN T cell homeostasis. They posi-
tively affect the development of HEVs and thus the T cell homing
capacity to LNs. Furthermore, DCs affect the production of
CCL21 in LNs and promote its ‘‘presentation,’’ thereby prolong-
ing the dwell time of T cells within LNs.
EXPERIMENTAL PROCEDURES
Animals
Mice were bred at the central animal facility of Hannover Medical School under
specific pathogen-free conditions or purchased from Charles River. The
following mouse strains were used: C57BL/6; B6.129P2(C)-Ccr7tm1Rfor/J 1,
backcrossed on C57BL/6 for >15 generations (designated Ccr7/); B6.Cg-
Tg(Cd4-cre)1Cwi (designated Cd4-cre+); B6.Cg-Tg(Itgax-cre)1-1Reiz/J
(designated Cd11c-cre+); B6.Sv129-Rag2tm1 (designated Rag2/); and
C57BL/6-rosa26(SA-CrepA) (designated germline deleter). All animal experi-
ments have been approved by the institutional review board and local
authorities.
Humanized CCR7 Mice
A detailed description of the conditional humanizedCCR7-proficient mice can
be found in the Supplemental Information.
Antibodies
The following antibodies and conjugates were used in this study: rat
anti-human CCR7 mAb (clone 3D12), rat anti-mouse CCR7 (clone 4B12),
anti-CD4-PerCp, anti-MHCII(I-Ab), anti-CD11c-biotin, anti-Meca79 (BD
Biosciences), anti-CD19-FITC (Southern Biotechnologies), anti-CD62L-PE,
anti-CD117-PE (Caltag), and anti-CD31-PE (PharMingen). Anti-CD3 (clone
17A2), anti-B220-Cy3 (clone TIB 146), anti-IgD (clone HB250), and anti-CD8-
FITC (clone RM CD8) antibodies were produced in our laboratories. Bio-
tinylated antibodies were recognized by streptavidin coupled to Alexa488
(Molecular Probes). Unconjugated anti-human and anti-mouse CCR7 anti-
bodies were revealed by mouse anti-rat-Cy5 (Jackson Laboratories). FITC-,
Cy3-, and Cy5-conjugates of anti-IgD, anti-CD3, and anti-CD8b antibodies
were prepared as recommended by the manufacturer (Amersham).
Flow Cytometry
LNs and spleenwereminced through a nylonmesh andwashed with PBS sup-
plemented with 3% FCS. Erythrocytes of blood and spleen were lysed with
a buffer containing ammonium chloride (1.7 M), potassium hydrogen
carbonate (100 mM), and EDTA (1 mM). For LN preparation containing endo-
thelial and stromals cells, LNs were treated with 564 U/ml collagenase type 2
(Worthington Biochemical) + 40 mg/ml DNase I (Sigma-Aldrich) for 30 min at
37C. The cell suspension was resuspended 40 times with a Pasteur pipette.
EDTA was added to a final concentration of 10 mM EDTA. After passing cell
suspension through a 70 mm filter, cells were stained with antibodies as
described above and analyzed with a FACSCalibur or LSRII (BD Biosciences).
Immunohistology and Measurement of High Endothelial Venule
Length
Organs were embedded in OCT and 8 mm cryosections were cut. Sections
were air-dried and fixed in ice-cold acetone for 10 min and stained with indi-
cated antibodies as described earlier (Pabst et al., 2005). Slides were analyzed
with an Axiovert 200M microscope and Axiovision software (Carl Zeiss) or an
IX81 microscope and analySISD software (Olympus). HEV length and LN
section area was calculated with ImageJ software.
In Vitro Differentiation and Transfer of DCs
A total of 23 106 bonemarrow cells from tibia and femur of mice were cultured
in RPMI 1640, 10%FCS, b-ME, glutamine, and penicillin/streptomycin supple-
mented with 100–200 ng/ml GM-CSF produced by a recombinant cell line for
8 days. In some experiments, cells were matured for 2 additional days with
1 mg/ml PGE2 (Sigma-Aldrich) and 30 ng/ml TNF-a (PeproTech). For DC trans-
fer, semimature BMDCs were gathered at day 8, labeled with 5mM CFSE;Isubsequently, 1 to 3 3 106 BMDCs were injected s.c. in the femoral leg, the
flank of the mice, or the footpad.
Binding of CCL21 to DCs
We incubated 5 3 105 to 1 3 106 in vitro differentiated DCs in 100 ml with
250 ng murine CCL21 (R&D Systems) for 30 min. Cells were washed twice in
PBS and blocked with 1% BSA in PBS containing Fc-block (diluted 1:100;
BD Biosciences) for 15 min. Rabbit anti-CCL21 (PeproTech,) diluted to 1 mg/ml
in PBS was incubated for 30 min; cells were washed twice in PBS before
anti-rabbit PE secondary antibody (Jackson ImmunoResearch) was incubated
for 30min. Alternatively, we used a goat-anti-CCL21 (R&D Systems) Ab, which
was revealed by a biotinylated donkey-anti-goat antibody (Jackson) and then
by streptavidin-PerCP (BD Biosciences). In some experiments, NaClO3 was
added to the BMDCs cultures at 50–75 mM 3 and 1 day prior staining with
CCL21. Presence of endogenous CCL21 on LN DCs was revealed as
described for BM DCs.
Chemotaxis Assay and In Vitro Inhibition
We resuspended 13 106 splenic cells or in vitro differentiated BMDCs in 100 ml
RPMI and loaded them in collagen-coated transwells (Corning BV, 5 mm pore
size) that were placed in 24-well plates containing 400 ml medium or medium
supplemented with 100 nM to 300 mM CCL21. After incubation for 3 hr at
37C, cells migrated were collected, counted, and stained with mAb for deter-
mining the number of migrated T cells by flow cytometry.
Skin Painting
The skin of the ears was painted two times with 0.1% Fluoresceinisothiocya-
nate (FITC) in acetone/dibutylphthalate (1:1). Twenty-four hours later, the mice
were sacrificed, the facial LNs were isolated, and single-cell suspensions were
prepared. The frequency of cells positive for CD11c, MHC II, and FITC were
determined by flow cytometry.
In Vivo Migration
Splenic lymphocytes were isolated as described above. We preincubated
2 3 106 cells/ml at 37C for 30 min in RPMI 1640 containing 5% FCS, incu-
bated them with 5 mM CFSE or TAMRA for 10 min at 37C, and washed
them in ice-cold PBS with 3% FCS. We mixed 5 3 106 cells of each color
and i.v. transferred them into the tail vein of recipients. Three hours later,
mice were sacrificed and lymphocytes were isolated from different organs.
The ratio or total number of recovered CFSE- and TAMRA-labeled T cells
was determined by flow cytometry. Ratios obtained were corrected for the
ratio present in the injected mixtures. For analyzing the location of T cells in
relation to HEV position T cells of C57BL/6 donors were enriched by MACS-
sorting with biotinylated anti-B220 mAb and streptavidin beads (Miltenyi). A
total of 1 3 106 TAMRA-labeled T cells were i.v. transferred in C57BL/6
wild-type and T-CCR7+/+ recipients. Mice were sacrificed; the LNs were iso-
lated and frozen in OCT.
Stable Bone Marrow Chimeras
Bone marrow was prepared from femurs and tibiae of T-CCR7+/+ and Rag2/
mice and then separated on Lympholyte M. Recipients for bonemarrow trans-
plantation were 6- to 8-week-old sex-matched T-CCR7+/+mice. Before trans-
plantation, adult recipient mice were lethally irradiated (5 Gy) twice at an
interval of 4 hr. Approximately 1.5 3 107 bone marrow cells were transferred
to irradiated recipients. For mixed chimeras, 80% Rag2/ and 20%
T-CCR7+/+ bone marrow were mixed before transplantation. Control animals
received 100% T-CCR7+/+ bone marrow cells. Three to four weeks later,
chimeras were shaved and UV irradiated for 30 min. UV irradiation mobilizes
DCs of the skin and their progenitors to allow for replacement of these cells.
Chimeric mice were analyzed 11–12 weeks after transplantation.
Treatment with Blocking Antibodies
To block homing of lymphocytes to LNsmice received each i.p. and i.v. 125 mg
anti-L-selectin (clone MEL-14).
Real-Time PCR
RNAwas isolated from cells via the Absolutely RNAMicroprep Kit (Stratagene)
and converted into cDNA (Superscript II reverse transcriptase, Invitrogen) withmmunity 35, 945–957, December 23, 2011 ª2011 Elsevier Inc. 955
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2.0 (Roche) with the SYBR Premix Ex Taq Kit (Takara). The primers used are
listed in the Supplemental Information.
Isolation of FRCs
Inguinal, axillary, brachial, and popliteal LNs were pooled from mice, mechan-
ically disrupted, and digested with Liberase (Roche). CD45.2-positive cells
were removed by MACS. The remaining cells were stained with antibodies
to gp38, CD24 and CD45.2, and Dapi. CD45.2 negative, gp38+ CD24 DAPI
cells were sorted. Greater than 97% of the sorted cells were CD45.2 with
more than 85% of these cells expressing gp38.
SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/j.
immuni.2011.10.017.
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